NEW YORK, Aug. 27, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Deltek, Inc. ("Deltek" or the "Company") (NASDAQ: PROJ) concerning the proposed acquisition of the Company by Thoma Bravo LLC ("Thoma Bravo") in a transaction valued at approximately $1.1 billion.
On August 27, 2012, it was announced that Deltek and Thoma Bravo have entered into a definitive agreement pursuant to which Thoma Bravo will acquire Deltek. Under the agreement, Deltek shareholders will receive $13.00 in cash per share held. At least one analyst has set a target price for Deltek stock of $16.00.
Our investigation concerns whether the Deltek board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders.
If you own Deltek shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Benjamin Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising.© 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP